These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 32994812)

  • 1. Metformin regulation of progesterone receptor isoform-B expression in human endometrial cancer cells is glucose-dependent.
    Saguyod SJU; Alhallak I; Simmen RCM; Velarde MC
    Oncol Lett; 2020 Nov; 20(5):249. PubMed ID: 32994812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin Promotes Anti-tumor Biomarkers in Human Endometrial Cancer Cells.
    Pabona JMP; Burnett AF; Brown DM; Quick CM; Simmen FA; Montales MTE; Liu SJ; Rose T; Alhallak I; Siegel ER; Simmen RC
    Reprod Sci; 2020 Jan; 27(1):267-277. PubMed ID: 32046384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of metformin in inhibiting estrogen-induced proliferation and regulating ERα and ERβ expression in human endometrial cancer cells.
    Zhang J; Xu H; Zhou X; Li Y; Liu T; Yin X; Zhang B
    Oncol Lett; 2017 Oct; 14(4):4949-4956. PubMed ID: 29085506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidermal growth factor receptor signaling pathway involved in progestin-resistance of human endometrial carcinoma: In a mouse model.
    Xu Y; Tong J; Ai Z; Wang J; Teng Y
    J Obstet Gynaecol Res; 2012 Dec; 38(12):1358-66. PubMed ID: 22612393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpressed epidermal growth factor receptor (EGFR)-induced progestin insensitivity in human endometrial carcinoma cells by the EGFR/mitogen-activated protein kinase signaling pathway.
    Ai Z; Wang J; Wang Y; Lu L; Tong J; Teng Y
    Cancer; 2010 Aug; 116(15):3603-13. PubMed ID: 20564127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of estrogen and endocrine therapeutic agents on the estrogen receptor, progesterone receptor and DNA synthesis in MCF-7 human breast cancer cells using the whole cell uptake method].
    Kurebayashi J; Horiuchi R; Nakamura T; Iino Y; Ishida T; Takigawa H; Izuo M
    Nihon Naibunpi Gakkai Zasshi; 1987 Nov; 63(11):1351-63. PubMed ID: 2965035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Functional study of progesterone receptor isoforms in endometrial cancer cell lines].
    Lu Y; Liao QP; Chen CL; Yu L
    Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Oct; 38(5):475-9. PubMed ID: 17068617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of the AMP-kinase modulators AICAR, metformin and compound C on insulin secretion of INS-1E rat insulinoma cells under standard cell culture conditions.
    Langelueddecke C; Jakab M; Ketterl N; Lehner L; Hufnagl C; Schmidt S; Geibel JP; Fuerst J; Ritter M
    Cell Physiol Biochem; 2012; 29(1-2):75-86. PubMed ID: 22415077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin inhibits 17β-estradiol-induced epithelial-to-mesenchymal transition via βKlotho-related ERK1/2 signaling and AMPKα signaling in endometrial adenocarcinoma cells.
    Liu Z; Qi S; Zhao X; Li M; Ding S; Lu J; Zhang H
    Oncotarget; 2016 Apr; 7(16):21315-31. PubMed ID: 26824324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resveratrol exhibits cytostatic and antiestrogenic properties with human endometrial adenocarcinoma (Ishikawa) cells.
    Bhat KP; Pezzuto JM
    Cancer Res; 2001 Aug; 61(16):6137-44. PubMed ID: 11507064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stromal PRs mediate induction of 17beta-hydroxysteroid dehydrogenase type 2 expression in human endometrial epithelium: a paracrine mechanism for inactivation of E2.
    Yang S; Fang Z; Gurates B; Tamura M; Miller J; Ferrer K; Bulun SE
    Mol Endocrinol; 2001 Dec; 15(12):2093-105. PubMed ID: 11731611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metformin inhibits estradiol and progesterone-induced decidualization of endometrial stromal cells by regulating expression of progesterone receptor, cytokines and matrix metalloproteinases.
    Xiong F; Xiao J; Bai Y; Zhang Y; Li Q; Lishuang X
    Biomed Pharmacother; 2019 Jan; 109():1578-1585. PubMed ID: 30551411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Krüppel-like factor 12 decreases progestin sensitivity in endometrial cancer by inhibiting the progesterone receptor signaling pathway.
    Shi H; Li J; Yan T; Zhou L; Zhu Y; Guo F; Yang S; Kong X; Zhou H
    Transl Oncol; 2024 Sep; 47():102041. PubMed ID: 38959708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of metformin on the estrogen-induced proliferation and the expression of ER in human endometrial cancer cells].
    Zhang J; Zhang B; Yin Z; Chen F; Liu T; Xu H; Liu Y; Zhou X
    Zhonghua Fu Chan Ke Za Zhi; 2014 Dec; 49(12):932-7. PubMed ID: 25608995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormone serum levels and hormone receptor contents of endometria in women with normal menstrual cycles and patients bearing endometrial carcinoma.
    Spona J; Ulm R; Bieglmayer C; Husslein P
    Gynecol Obstet Invest; 1979; 10(2-3):71-80. PubMed ID: 535775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin promotes progesterone receptor expression via inhibition of mammalian target of rapamycin (mTOR) in endometrial cancer cells.
    Xie Y; Wang YL; Yu L; Hu Q; Ji L; Zhang Y; Liao QP
    J Steroid Biochem Mol Biol; 2011 Sep; 126(3-5):113-20. PubMed ID: 21168492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin and AICAR regulate NANOG expression via the JNK pathway in HepG2 cells independently of AMPK.
    Shen C; Ka SO; Kim SJ; Kim JH; Park BH; Park JH
    Tumour Biol; 2016 Aug; 37(8):11199-208. PubMed ID: 26939902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect and regulation of metformin on endometrial carcinoma subline of progestin-resistance].
    Niu YJ; Shi HR; Xie Y
    Zhonghua Fu Chan Ke Za Zhi; 2016 Feb; 51(2):135-40. PubMed ID: 26917483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High Glucose-Mediated STAT3 Activation in Endometrial Cancer Is Inhibited by Metformin: Therapeutic Implications for Endometrial Cancer.
    Wallbillich JJ; Josyula S; Saini U; Zingarelli RA; Dorayappan KD; Riley MK; Wanner RA; Cohn DE; Selvendiran K
    PLoS One; 2017; 12(1):e0170318. PubMed ID: 28114390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proliferation and metastatic potential of endometrial cancer cells in response to metformin treatment in a high versus normal glucose environment.
    de Barros Machado A; Dos Reis V; Weber S; Jauckus J; Brum IS; von Eye Corleta H; Strowitzki T; Capp E; Germeyer A
    Oncol Lett; 2016 Nov; 12(5):3626-3632. PubMed ID: 27900046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.